The company organizes new employee induction training
Release time:
2021-09-13
"Growth is more important than success. I hope everyone can become the backbone and pillars of the peak as soon as possible." 9# February 2 , Yu Jianhong, general manager of the group company, put forward ardent hopes in the face of new employees. 2 and 3 , the group company organized induction training for new employees recruited in the past year. Jiang Xiaomeng, chairman of the group company, Yu Jianhong, general manager, and other leaders and heads of relevant departments gave lectures to them.
In the first lesson of the induction training, General Manager Yu Jianhong introduced the company's industrial layout and basic situation from the aspects of cement, medicine, health, etc.; from the aspects of hard work, determined reform, diversified development, strategic adjustment, strategic development, etc. Several stages, narrated the development process of the peak; from the enterprise spirit, vision, development concept, talent view, work style and other contents systematically expounds the enterprise culture of the peak. He hopes that new employees can be the best themselves in the process of growing up, persist in learning in all aspects, constantly sum up themselves, improve their abilities, and grow into the backbone of the sustained and healthy development of the peak as soon as possible.
Chairman Jiang Xiaomeng elaborated on the key words 18 that a new peak person needs to understand under the title "How to Grow with the Enterprise. He said that the key to the success of an enterprise lies in selecting, retaining, educating and employing people. Based on his own experience and actual cases, Jiang Xiaomeng shared with new employees the five necessary elements for excellent employees, the ten habits of how to achieve success and self-improvement. He hoped that new employees would adjust their mentality in time, define their goals and dreams, persist in learning, reduce dependence, be a person with win-win thinking, and become the talents needed by the enterprise as soon as possible.
In order to enable new employees to integrate into the enterprise better and faster, in addition to the lectures given by the chairman and general manager, the relevant persons in charge of the Group's Safety Management Office and the Human Resources Department also explained in detail the safety knowledge, enterprise rules and regulations and the Employee Handbook for new employees. The new employees also visited the company's showroom and gained a deeper understanding of the entrepreneurial development and corporate culture of the peak.
After the training, the Human Resources Department also organized an examination for new employees to test the training effect. New employees of foreign enterprises such as Daye Peak, Yunnan Peak, Huang Ping Peak and Shanghai North Carolina participated in the training through video conference system.
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page